Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain

Journal of Health Economics and Outcomes Research
doi 10.36469/9811
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Columbia Data Analytics

Related search

Transdermal Oxybutynin: What Role in the Management of Overactive Bladder?

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2010English

Oxybutynin Extended Release for the Management of Overactive Bladder: A Clinical Review

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2009English

Development of Oxybutynin Chloride Topical Gel for Overactive Bladder

Research and Reports in Urology
Urology
2011English

PUK10 Cost-Effectiveness Analysis of Solifenacin Versus Oxybutynin Immediate-Release in the Treatment of Patients With Overactive Bladder in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Economic Impact of Overactive Bladder Symptoms in Japan

Japanese Journal of Urology
Urology
2008English

OnabotulinumtoxinA for the Treatment of Overactive Bladder

Research and Reports in Urology
Urology
2014English

The Efficacy and Safety of Uractiv Control in Overactive Bladder Treatment

Revista de Chimie
SurfacesMaterials ScienceEngineeringMaterials ChemistryFilmsCoatingsChemistry
2020English

Botulinum Toxin a for the Treatment of Overactive Bladder

Toxins
MutagenesisToxicologyHealth
2016English

Correction To: Imidafenacin for the Treatment of Overactive Bladder

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy